Rasmus West Knopper

Mr. Rasmus West Knopper

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2023 in Cancer Letters
Verified
Journal Article
Open access
JJJustin V. Joseph
Justin V. Joseph
MBMathilde S. Blaavand
Mathilde S. Blaavand
HCHuiqiang Cai
Huiqiang Cai
FVFabienne Vernejoul
Fabienne Vernejoul
RKRasmus West Knopper
Rasmus West Knopper
MTMartin Thomsen
Martin Thomsen
Glioblastoma (GBM) is an aggressive brain tumor with a median survival of 15 months and has limited treatment options. Immunotherapy with checkpoint inhibitors has shown minimal efficacy in combating GBM, and large clinical trials have failed. New immunotherapy approaches and a deeper understanding of immune surveillance of GBM are needed to advance treatment options for this devastating disease. In this study, we used two preclinical models of GBM: orthotopically delivering either GBM stem cells or employing CRISPR-mediated tumorigenesis by adeno-associated virus, to establish immunologically proficient and non-inflamed tumors, respectively. After tumor development, the innate immune system was activated through long-term STING activation by a pharmacological agonist, which reduced tumor progression and prolonged survival. Recruitment and activation of cytotoxic T-cells were detected in the tumors, and T-cell specificity towards the cancer cells was observed. Interestingly, prolonged STING activation altered the tumor vasculature, inducing hypoxia and activation of VEGFR, as measured by a kinome array and VEGF expression. Combination treatment with anti-PD1 did not provide a synergistic effect, indicating that STING activation alone is sufficient to activate immune surveillance and hinder tumor development through vascular disruption. These results guide future studies to refine innate immune activation as a treatment approach for GBM, in combination with anti-VEGF to impede tumor progression and induce an immunological response against the tumor.

13 October 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
EWEmil Westi
Emil Westi
SMSaba Molhemi
Saba Molhemi
CHCaroline Termøhlen Hansen
Caroline Termøhlen Hansen
CSChristian Stald Skoven
Christian Stald Skoven
RKRasmus West Knopper
Rasmus West Knopper
BABlanca Irene Aldana
Blanca Irene Aldana
Alzheimer’s disease (AD) is characterized by complex interactions between neuropathological markers, metabolic dysregulation, and structural brain changes. In this study, we utilized a multimodal approach, combining immunohistochemistry, functional metabolic mapping, and microstructure sensitive diffusion MRI (dMRI) to progressively investigate these interactions in the 5xFAD mouse model of AD. Our analysis revealed age-dependent and region-specific accumulation of key AD markers, including amyloid-beta (Aβ), GFAP, and IBA1, with significant differences observed between the hippocampal formation and upper and lower regions of the cortex by 6 months of age. Functional metabolic mapping validated localized disruptions in energy metabolism, with glucose hypometabolism in the hippocampus and impaired astrocytic metabolism in the cortex. Notably, increased cortical glutaminolysis suggested a shift in microglial metabolism, reflecting an adaptive response to neuroinflammatory processes. While dMRI showed no significant microstructural differences between 5xFAD and wild-type controls, the study highlights the importance of metabolic alterations as critical events in AD pathology. These findings emphasize the need for targeted therapeutic strategies addressing specific metabolic disturbances and underscore the potential of integrating advanced imaging with metabolic and molecular analyses to advance our understanding of AD progression.

15 March 2026 in Cell Biochemistry and Function
Verified
Journal Article
Open access
PDF file
LJLaura Øllegaard Johnsen
Laura Øllegaard Johnsen
RHRasmus Herløw
Rasmus Herløw
RKRasmus West Knopper
Rasmus West Knopper
TLThomas Beck Lindhardt
Thomas Beck Lindhardt
BHBrian Hansen
Brian Hansen
HDHelle Damkier
Helle Damkier
Posthemorrhagic hydrocephalus is a severe complication to intraventricular hemorrhage. The condition results in enlarged brain ventricles and increased intracranial pressure due to accumulation of cerebrospinal fluid (CSF). In this study, two mouse models of intraventricular hemorrhage were investigated: injection of lysed red blood cells (LRBC) and injection of autologous full blood. CSF secretion and ventricular volume were assessed using ventriculo‐cisternal perfusion and magnetic resonance imaging (MRI), while molecular and biochemical responses were analyzed by immunoblotting, RT‐qPCR, flame photometry, and blood‐gas measurements. LRBC injection induced a transient change in choroid plexus bicarbonate transporter expression, as the protein‐abundance of Ncbe, a basolateral sodium‐bicarbonate transporter, was reduced by 23% after 24 h but increased by 17% after 48 h. Injection with full blood transiently increased mRNA levels of the basolateral sodium‐bicarbonate transporter NBCn1 and Ncbe without altering protein expression. The luminal electrogenic sodium: bicarbonate transporter, NBCe2, was unaffected both at the RNA and protein level. Both models were validated using ventriculo‐cisternal perfusion demonstrating an increase in CSF volume by 70% in the IVH model after 24 h and 73% in the LRBC model after 3 days. No effect on secretion rate of CSF was detected. Additionally, in the LRBC model MRI was used to assess the time‐course of brain ventricle size following hemorrhage. Here, an overall volume increase of 30% was found in the hemorrhage‐induced mice compared to the control. These results demonstrate that both LRBC and full‐blood injections can induce ventricular enlargement in mice, but through different molecular responses. Neither model reproduced sustained CSF hypersecretion, underscoring that murine models of intraventricular hemorrhage display a milder form of pathophysiology compared to e.g. rats.

6 June 2026 in Neurobiology of Disease
Verified
Journal Article
Open access
RKRasmus West Knopper
Rasmus West Knopper
BHBrian Hansen
Brian Hansen
Sleep and brain health are closely coupled, yet the mechanisms underlying this relationship remain incompletely understood. The locus coeruleus (LC) is a key modulator of sleep architecture, and LC dysfunction (LCd) is implicated in a wide range of neurodegenerative and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, depression, and post-traumatic stress disorder. The isolated effects of LCd on sleep and brain health cannot be studied in humans, but they can be modeled in animals using the noradrenergic neurotoxin DSP4, which produces chronic and selective LC degeneration. Here, we provide a systematic review of the impact of DSP4-based LC ablation on sleep. We summarize the substantial (and often under-reported) variability in DSP4 outcomes and place these findings in the broader context of LC physiology and pathology. We then review DSP4's mechanism of action and identify methodological and biological factors likely contributing to the pronounced inter-study variability. Finally, we offer practical considerations to support more consistent DSP4-based LC ablation, enabling robust investigation of the consequences of chronic LCd for sleep architecture and overall brain health.

1 September 2024
Verified
Preprint
Open access
RKRasmus West Knopper
Rasmus West Knopper
CSChristian Stald Skoven
Christian Stald Skoven
SESimon Eskildsen
Simon Eskildsen
LØLeif Østergaard
Leif Østergaard
BHBrian Hansen
Brian Hansen
Background and Purpose: The locus coeruleus (LC) produces the majority of brain noradrenaline (NA). Among its many roles, NA has a protective role for cells in the central nervous system. Loss of LC integrity is, therefore, thought to cause alterations to brain volume and microstructure, possibly driving the development of neurodegenerative diseases. Experimental Approach: Ablation effect is ascertained by behaviour analysis prior to ex vivo investigations. We use high-field magnetic resonance imaging (MRI) to investigate brain volumetrics and microstructure in control (CON) mice and mice with LC ablation (LCA) at two ages. Our study employs whole-brain methods known to be capable of detecting subtle morphological changes and brain microstructural remodelling. Key Results: Mice show behaviour consistent with histologically confirmed LC ablation. However, MRI shows no difference between CON and LCA groups with regard to brain size, relative regional volumes, or regional microstructural indices. Conclusion and Implications: Our study suggests that LC-NA is not needed for postnatal brain maturation and growth in mice. Nor is it required for maintenance in the normal, adult mouse brain. This adds clarity to the often-encountered notion that LC-NA is important for brain ”trophic support” as it shows that such effects are likely most relevant to mechanisms related to brain plasticity and neuroprotection.

18 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EGEugenio Gutiérrez-Jiménez
Eugenio Gutiérrez-Jiménez
BWBoris Wied
Boris Wied
TLThomas B. Lindhardt
Thomas B. Lindhardt
SMSigne H. Mikkelsen
Signe H. Mikkelsen
RKRasmus West Knopper
Rasmus West Knopper
LØLeif Østergaard
Leif Østergaard
Sex differences in brain aging are well documented, but their origin within the cerebrovascular hierarchy remains unclear. Here we show that cortical blood flow is higher in female than male mice at 15 months of age, at a point when an earlier sex difference in pulsatility and resistance indices has already converged, pial vessel diameter shows no difference between sexes, and estrogen levels are similar between sexes. Using an indicator-dilution and intravascular oxygen measurements using two-photon microscopy, we found that capillary transit-time heterogeneity (CTH) scales more steeply with mean transit time in females, consistent with a passively regulated capillary network, and that this is accompanied by reduced oxygen extraction fraction (OEF) without deficit in arterial oxygen delivery. Spatial transcriptomics reveals that sex differences are organized into distinct regional programs, most prominently in white matter, where a male-associated myelin and axonogenesis signature accompanies reduced white matter volume in females. These molecular and structural differences coincide with elevated hippocampal microglial reactivity and an altered spatial search strategy in females, without any detectable differences in circulating markers of stress, blood-brain barrier integrity, or immunity. Together, these findings indicate that sex differences in the aging brain are expressed at the level of capillary flow regulation and regional tissue programs rather than through bulk cerebral blood flow alone, and that elevated blood flow in females can mask, rather than reflect, adequate tissue oxygenation.